DUBLIN-Research and Markets has announced the addition of the "The Pharmaceutical Market: Bulgaria" report to their offering.
Funding for healthcare in Bulgaria is principally through compulsory health insurance, operated by the National Health Insurance Fund. The role of the NHIF is to provide a basic package of health services for the whole population. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Bulgaria is located in south-eastern Europe, bordering Romania, Serbia, Macedonia, Greece and Turkey and is one of the newest members of the EU, joining in January 2007, alongside Romania. The population of Bulgaria is estimated at 7.5 million in 2009, nearly 18% of which is aged 65 or over.
Funding for healthcare in Bulgaria is principally through compulsory health insurance, operated by the National Health Insurance Fund. The role of the NHIF is to provide a basic package of health services for the whole population. The government is divided on whether to allow private companies to operate in the insurance sector. Two of the three coalition parties support the idea of removing the NHIF's monopoly, unlike the senior partner, the Bulgarian Socialist Party.
In 2008, the Bulgarian market for pharmaceuticals was estimated at US$771 million, or US$102 per capita. It is expected that the market will continue to expand at a rate of 5.1% per annum, reaching US$989 million, equal to US$136 per capita, by 2013. An estimated 78% of the pharmaceutical market is supplied by imports. Germany and Switzerland were the leading suppliers in 2006, accounting for over 30% of imports. The value of imports increased by 11.8% in 2006.
These in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Key Topics Covered:
- Executive Summary
- Pharmaceutical Market Analysis
- Local Manufacturers
- Pharmaceutical Regulatory Analysis
- Pharmaceutical Distribution
- Retailing
- Directory
- Methodology & Sources
- List Of Tables
- List Of Charts
Companies Mentioned:
- Actavis (Higia AD)
- Commercial League
- Kaliman RT
- Phoenix-Libra
- Sopharma
- Sting
No comments:
Post a Comment